Article Archive
Alain Beaudet named president of CIHR in Canada
31 March 2008
UCB drops 12% on Neupro batches recall
31 March 2008
Humana hit by Rx cost increases in USA
31 March 2008
Clinical hold on Heplisav by FDA
31 March 2008
Japan's No 1 generics group formed
31 March 2008
Daiichi Sankyo extends MorphoSys accord
31 March 2008
Sanofi-Aventis to help market Lilly's Cialis in USA
31 March 2008
Celgene's amrubicin gets US OD designation
31 March 2008
Shire signs US co-promotion deal with TAP for Lialda
31 March 2008
Stephamie Kelly named Actelion UK/Ireland brand manager
31 March 2008
Peter Edman becomes CSO at Biovitrum
31 March 2008
pSivida amends Medidur deal with Alimera
31 March 2008
Ardana updates on sale or merger plans
31 March 2008
$5.8M Defense Dept contract for PharmAthene
31 March 2008
Pharming grants EIP rights to Rhucin in Turkey
31 March 2008
Pieris raises 25M euros in financing round
31 March 2008
Akesis closes $2M placing
31 March 2008
Wyeth milestone for ArQule on AD drug
31 March 2008
TAP/Takeda appointments post-JV dissolution
31 March 2008
BioAlliance gains three more EU Loramyc approvals
31 March 2008
Saudi Arabia publishes biosimilars regulation
31 March 2008
Stock Commentary - New York week to March 24, 2008
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
E-mail drug alerts for US physicians launched
31 March 2008
Forthcoming meetings and conferences
31 March 2008
Medarex gets Centocor milestone
31 March 2008
Trius raises $30M in series B financing
31 March 2008
Corcept initiates fourth Ph II Corlux study
31 March 2008
Alnylam research prod deal with Shanghai GenePharma
31 March 2008
Honeywell ups production of Aclar for pharma industry
31 March 2008
Iomai's patch adjuvants flu vacc efficacy to 73%
31 March 2008
LB analysts: Shire is "heavily" over-valued
31 March 2008
Hikma's full-year 2007 revenue jumps 41.6%
31 March 2008
Regeneron's Arcalyst available in USA
31 March 2008
Levitra helps ED patients with high cholesterol
31 March 2008
58.5% of Actemra patients achieve ACR20
31 March 2008
California drug RFID scheme faces delays
31 March 2008
China Biopharma to launch MNC's drugs
31 March 2008
Biovail to pay $10M over SEC charges
31 March 2008
Cost-cutting by drugmakers in Germany
31 March 2008
Spain's pharma price strategy limited
31 March 2008
Lilly settles Zyprexa Alaska case for $15M
31 March 2008
"Last chance" cancer drugs for UK patients
31 March 2008
Hollis-Eden's 4th-qtr net loss narrows to $5.2M on payments for Triolex; files four US INDs in 2007
31 March 2008
Japan stock market week to March 24, 2008
31 March 2008
CHMP recommends expanded label for Zevalin
31 March 2008
EMEA warns of liver injury with Tysabri
31 March 2008
EMEA restricts use of Millennium/J&J's Velcade
31 March 2008
Pharming to resubmit Rhucin MAA
31 March 2008
EPIX discontinues MDD drug on poor efficacy
31 March 2008
FDA clears Cephalon's Treanda for CLL
31 March 2008
CytRx responds to FDA's Ph IIb hold on ALS drug
31 March 2008
Merck & Co's Gardasil gets priority US review
31 March 2008
Market slowdown for dyslipidemia drugs
31 March 2008
Tongjitang buys Qinghai Pulante
31 March 2008
Isolagen sells Swiss facility for $6.4M
31 March 2008
Potential of Russia's biotech sector
31 March 2008
PharmAthene to buy Avecia business
31 March 2008
Kenya health sector reforms should see parallel importing of drugs and local manufacturing
31 March 2008
Gene methylation linked to NSCLC recurrence
31 March 2008
Thailand's GPO: CVD and ARV copycats plan
31 March 2008
US House C'tee declines to press contempt charge
31 March 2008
US heparin deaths rise to 15, contaminant identified
31 March 2008
Genzyme withdraws Evoltra label extension
31 March 2008
US MDs do not Rx to HLD guidelines
31 March 2008
CVS pays c$37M to settle US Rx case
31 March 2008
US drug price growth modest, says PhRMA
31 March 2008
UK drugmaker confidence crashes
31 March 2008
Belgium's drugmakers welcome 26 new drugs
31 March 2008
Delay to EU approval of GSK
31 March 2008
Alimera closes $30M financing; ups stake in Medidur
31 March 2008
ZephyrBiotech set up to help early-stage firms
31 March 2008
Cytopia selects JAK2 MPDS candidate
31 March 2008
Ph III Tavocept efficacy "needs verification"
31 March 2008
Telaprevir enters Ph III trial in chronic HCV
31 March 2008
Cardiome seeks partner to further vernakalant
31 March 2008
Locaserin trial passes 1-year safety review
31 March 2008
Stock Commentary - New York week to March 17, 2008
24 March 2008
Delay to ceftobiprole's US approval
24 March 2008
SMC approves Shire's Mezavant XL for UC
24 March 2008
- GlaxoSmithKline’s Avandia still available in UK, despite MHRA call for its suspension
- Israel relaxes restrictions on medical marijuana; scientists develop new HIV/AIDS treatment
- Tough road ahead for some generics after USA’s Federal Circuit Patent Use Code decisions
- Bausch & Lomb moves to acquire Miochol-E from Novartis as required by US competition authority
- German drug price curbs will hamper orphan drug development, says BIO Deutschland
